Biotech & Pharma
biotech & pharma
Infrastructure Sourcing that Respects Compliance, Data integrity, and Research velocity.
Biotech and pharma environments often combine sensitive data, regulated workflows, bursty compute, and strict uptime requirements. We help teams choose vendors and architectures that are feasible, auditable, and operationally manageable—without slowing down R&D.
Common initiatives
These are the most frequent entry points we see for regulated and research-heavy environments.
Scale
Expand Compute and Storage for R&D
Support bursting workloads, data pipelines, and growing datasets with predictable performance.
Risk
Improve Resiliency & DR Readiness
Reduce single points of failure for critical systems and validate fail-over expectations.
Latency
Network Performance for Labs and Sites
Improve site-to-cloud and site-to-site performance for data-heavy lab workflows.
Audit
Security Posture Improvements
Reduce tool sprawl, clarify coverage, and align controls with operational reality.
Finance
Cost Transparency and Renewal Discipline
Baseline spend, normalize unit costs, and prevent renewal surprises.
Simplify
Vendor Consolidation
Standardize vendors and contracts across environments without losing resiliency.
Common constraints and buying considerations
These are the factors that typically drive vendor choice, architecture, and contract terms in biotech & pharma.
01
Constraints
- Auditability and evidence retention (changes, access, incident handling)
- Data integrity expectations (traceability, backups, retention, validation)
- Data residency and sovereignty requirements (region constraints)
- Strict change windows for regulated systems
- Vendor risk management and continuity planning
- Hybrid environments (lab + corporate + cloud + colocation)
02
What should be comparable in proposals
- Support model: coverage hours, escalation, named resources.
- SLA definitions: what counts as downtime, credits, response times
- Data handling: encryption, key management, retention, deletion
- Change management: maintenance windows, notification, approval workflows
- Compliance language: audit rights, reporting, breach notification
- Total cost of operations: egress, storage growth, add-ons, licensing
Relevant Solutions
Where biotech & pharma teams most often focus infrastructure work.
Cloud
Compute and storage for pipelines, analytics, and collaboration with governance controls.
Data Center / Colocation
Stable capacity, predictable performance, and physical controls for sensitive workloads.
Network Connectivity
Site-to-cloud connectivity, resilient paths, and SLAs aligned to critical workflows.
Wide Area Networks
SD-WAN/WAN design and rollout planning for distributed labs and offices.
Security
Controls mapping, vendor selection, and governance to prevent tool sprawl. Security layering and audits.
Unified Communications
Global collaboration and support models that work across teams and sites.
How We Help Biotech & Pharma Teams
Regulated environments and data integrity requirements with overwhelming storage
01
Sourcing Advisory (ongoing)
- Serviceability + options research
- Vendor selection support with compliance-relevant criteria
- Contract review and negotiation support (audit rights, SLAs, breach notification)
- Vendor management & escalation
- Renewal planning and lifecycle governance
02
Consulting (time-boxed)
- RFx toolkit & management (controlled, comparable responses)
- FinOps assessment (cloud cost governance)
- Migration & cutover management (runbooks + rollback)
- PMO for rollouts (multi-site programs)
- Network transformation (target state + rollout plan)
Frequently Asked Questions
Proposals should specify what logs are retained, for how long, how evidence is exported, and how access/change events are recorded. They should also document support escalation timelines and incident reporting mechanisms in a way that can be audited.
Common terms to surface early include: audit rights, breach notification timelines, data handling (retention/deletion), subcontractor controls, change notification/maintenance windows, SLA definitions, and termination assistance.
Validated environments tend to prioritize change control, traceability, and repeatability. Infrastructure choices should make it easy to demonstrate configuration consistency, access controls, and evidence of changes—without relying on manual processes.
Egress, inter-region data movement, storage growth, snapshots, managed service add-ons, licensing, and support tiers. A good comparison normalizes unit costs and calls out assumptions that change the total cost of operations.
Resiliency definitions should be tied to the specific workflow impact: acceptable downtime, recovery objectives, failover realism, and vendor support coverage. “Diverse” connectivity and “redundant” power should be defined with testable criteria.
Operational fit (who runs it), integration requirements, evidence/reporting outputs, response workflows, support model, and how coverage maps to controls. Feature lists are less useful than “can we operate this reliably and prove it?”
Vendor risk becomes real when support coverage, escalation paths, and continuity plans are unclear. Proposals should specify operational accountability and contract terms should include clear remedies, reporting, and exit assistance where needed.
Get Clarity on Your Next Move
Engage 515 Engine to help you achieve your infrastructure goals.